Breaking Barriers: Mozzaz Platform Achieves Milestone with over 20,000 Connected Diabetes Patients using CGM Devices
Philadelphia, PA – November 15, 2023
Mozzaz, at the forefront of digital health innovation, is thrilled to share recent achievements in diabetes management for providers utilizing the Mozzaz Platform. By seamlessly integrating data from various health devices, including continuous glucose monitors (CGM) such as FreeStyle Libre and Dexcom, digital weight scales, pulse oximeters, and more, Mozzaz provides a comprehensive solution that gives both patients and care providers a holistic view of their health.
1. Surpassing 20,000 Connected CGM Patients
We're excited to announce a major milestone – Mozzaz has now connected over 20,000 patients across both Abbott FreeStyle Libre and Dexcom CGMs! This achievement speaks to the growing trust and reliance on Mozzaz as a leading solution for diabetes management. By seamlessly aggregating data from CGMs and other connected-health devices, we empower patients and their care teams with near real-time insights, facilitating more informed and proactive decision-making outside of the traditional care setting.
2. High Levels of Patient Engagement: Fostering a Collaborative Care Ecosystem
Mozzaz continues to experience outstanding engagement with patients enrolled in programs utilizing our platform. Through an intuitive and user-friendly patient application (that can be white labelled to specific branding needs), we've successfully cultivated a sense of empowerment and collaboration among individuals managing diabetes. By providing a hub for patients to view health resources, their meal tracking, vital readings and more we not only collect data but actively involve patients in their care journey. Creating a collaborative ecosystem that enhances overall well-being and trust in the care experience.
These insights have allowed many people to make small, sustainable adjustments to better manage their diabetes:
84% of those who use sensor-based glucose monitoring systems agree that these digital health tools help them make small, sustainable lifestyle changes to improve their diabetes management
81% said that the more they knew about their condition, the more empowered and in control they felt
3. A Leap Forward in Outcomes: Achieving a 68% Time in Range (TIR)
The heart of our mission is to improve patient outcomes, and we're delighted to report significant progress. Mozzaz Platform users in programs for diabetes have achieved an impressive 68% Time in Range (TIR) value, representing a 32% improvement from pre-program. This metric is pivotal in diabetes management, reflecting the proportion of time individuals spend within their target glucose range. The substantial increase in TIR values is a testament to the effectiveness of Mozzaz in supporting patients towards healthier, more stable glucose levels.
4. Marked Reduction in Glucose Variability: Empowering Stability
Mozzaz has successfully contributed to a notable decrease in glucose variability among our users. By leveraging continuous glucose monitoring with platform workflows and analytics, we've facilitated a tangible improvement in stabilizing blood glucose levels, resulting in a significant 75% improvement in glucose variability. This achievement is a critical step towards promoting sustained health and minimizing the fluctuations that can impact a patient’s daily life.
As we celebrate these achievements, Mozzaz remains dedicated to pushing the boundaries of what's possible in digital health. We are committed to continuing our mission of enhancing patient outcomes, fostering engagement, and providing care teams with the tools they need for more personalized, proactive, and effective care.
For further information, please contact:
Duncan De Craemer
Duncan.decraemer@mozzaz.com
267-857-4189
